Rezolve AI Slams Commerce.com's 'Poison Pill' Amid Hostile Takeover Bid

summarizeSummary

Rezolve AI plc strongly criticized Commerce.com, Inc.'s adoption of a "poison pill" defense, calling it a desperate attempt to entrench its board and prevent shareholders from considering Rezolve AI's acquisition offer.

check_boxKey Events

• Poison Pill Adopted

  Commerce.com's Board of Directors adopted a stockholder rights plan, commonly known as a "poison pill," as a defensive measure against Rezolve AI's unsolicited acquisition offer.

• Rezolve AI Condemns Action

  Rezolve AI plc slammed the poison pill as a "desperate" attempt by Commerce.com's board to entrench itself and prevent shareholders from considering a value-maximizing offer.

• Board Competence Questioned

  Rezolve AI highlighted Commerce.com's 96% stock price decline from its post-IPO peak, questioning the board's competence ahead of the May 14 director election.

• Investor Call Scheduled

  Rezolve AI announced an investor call for April 15, 2026, at 0800 ET, to publicly present its strategic rationale for combining with Commerce.com.

auto_awesomeAnalysis

This filing marks a significant escalation in the hostile takeover attempt by Rezolve AI for Commerce.com. The adoption of a poison pill by Commerce.com's board is a strong defensive maneuver designed to make an unsolicited acquisition more difficult and costly, potentially diluting any acquirer's stake. Rezolve AI's immediate and strong condemnation, coupled with its assessment of the plan's legality and fiduciary duty, indicates a continued aggressive pursuit of the acquisition. Shareholders of Commerce.com will likely face increased uncertainty and volatility as this battle unfolds, particularly with the upcoming director election on May 14, 2026, and Rezolve AI's scheduled investor call.